טיפול בשילוב של מעכבי קולטן כימוקין 2 (ccr2) ומעכב pd-1/pd-l1
- 专利权人:
- CHEMOCENTRYX INC.
- 发明人:
- 申请号：
- IL27318820
- 公开号：
- IL273188D0
- 申请日:
- 2020.03.09
- 申请国别(地区):
- IL
- 年份:
- 2020
- 代理人:
- 摘要：
- The present disclosure is drawn to the combination therapy of a Chemokine Receptor 2 (CCR2) antagonist and a PD-1 and/or PD-L1 inhibitor in the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
- COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS
- COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
- Combination therapy using a Chemokine Receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
- Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
